Brugada P, Facchini M, Wellens H J
Am J Cardiol. 1986 Jan 1;57(1):146-9. doi: 10.1016/0002-9149(86)90969-0.
The effects of isoproterenol on induction of circus movement tachycardia were studied in 21 patients with an accessory atrioventricular pathway. Forty-six studies were performed. Thirteen patients were studied before and during administration of isoproterenol without antiarrhythmic drugs (group A). Ten patients (including 2 from group A) were studied before and during administration of isoproterenol while receiving oral treatment with amiodarone (group B). Ability to initiate circus movement tachycardia before or during administration of isoproterenol by programmed stimulation was correlated with the relation of circus movement tachycardia to exercise in these patients. (Seven patients in group A and 7 in group B had circus movement tachycardia related to exercise.) Isoproterenol significantly shortened sinus cycle length, duration of the QRS complex during sinus rhythm, anterograde effective refractory period of the accessory pathway, and circus movement tachycardia cycle length, owing to shortening of the AH interval during the arrhythmia. Isoproterenol made initiation of circus movement tachycardia possible in patients in whom the arrhythmia could not be initiated before. However, this effect did not correlate with the relation of the spontaneously occurring circus movement tachycardia to exercise. The electrophysiologic effects produced by isoproterenol did not differ between patients with and without exercise-related tachycardia. In all patients in whom circus movement tachycardia was initiated before administration of isoproterenol, the tachycardia was still inducible during administration of that drug. It is concluded that isoproterenol facilitates initiation of circus movement tachycardia in patients with an accessory pathway, mainly by facilitating anterograde conduction over the atrioventricular node.(ABSTRACT TRUNCATED AT 250 WORDS)
在21例患有房室旁道的患者中研究了异丙肾上腺素对诱发折返性心动过速的影响。共进行了46项研究。13例患者在未使用抗心律失常药物的情况下,于异丙肾上腺素给药前及给药期间进行了研究(A组)。10例患者(包括A组中的2例)在接受胺碘酮口服治疗的同时,于异丙肾上腺素给药前及给药期间进行了研究(B组)。通过程序刺激在异丙肾上腺素给药前或给药期间诱发折返性心动过速的能力,与这些患者中折返性心动过速与运动的关系相关。(A组7例患者和B组7例患者的折返性心动过速与运动有关。)异丙肾上腺素显著缩短了窦性周期长度、窦性心律时QRS波群的时限、旁道的前向有效不应期以及折返性心动过速的周期长度,这是由于心律失常期间AH间期缩短所致。异丙肾上腺素使之前无法诱发心律失常的患者能够诱发折返性心动过速。然而,这种作用与自发发生的折返性心动过速与运动的关系无关。有无运动相关性心动过速的患者,异丙肾上腺素产生的电生理效应并无差异。在所有异丙肾上腺素给药前即能诱发折返性心动过速的患者中,该药物给药期间仍能诱发心动过速。得出的结论是,异丙肾上腺素主要通过促进房室结的前向传导,促进旁道患者折返性心动过速的诱发。(摘要截选至250字)